|
ANKRD13C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.83279999457875E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76430003939743E-09 |
| Normal-vs-Stage2 |
8.415400E-04 |
| Normal-vs-Stage3 |
2.538600E-03 |
| Normal-vs-Stage4 |
1.134600E-01 |
| Stage1-vs-Stage2 |
9.177600E-01 |
| Stage1-vs-Stage3 |
3.873400E-01 |
| Stage1-vs-Stage4 |
5.591600E-01 |
| Stage2-vs-Stage3 |
5.888000E-01 |
| Stage2-vs-Stage4 |
6.806000E-01 |
| Stage3-vs-Stage4 |
9.805000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.15010001522364E-09 |
| Normal-vs-AfricanAmerican |
3.55809999996737E-06 |
| Normal-vs-Asian |
3.902000E-03 |
| Caucasian-vs-AfricanAmerican |
5.971800E-01 |
| Caucasian-vs-Asian |
9.759400E-01 |
| AfricanAmerican-vs-Asian |
8.776200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.24470475329986E-11 |
| Normal-vs-Female |
6.462300E-03 |
| Male-vs-Female |
1.264920E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.55740000000427E-05 |
| Normal-vs-Extreme_Weight |
8.25089996325801E-10 |
| Normal-vs-Obese |
2.45529999998162E-06 |
| Normal-vs-Extreme_Obese |
2.350400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.435600E-01 |
| Normal_Weight-vs-Obese |
7.702800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.974800E-01 |
| Extreme_Weight-vs-Obese |
2.001400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.371600E-01 |
| Obese-vs-Extreme_Obese |
8.554800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.056400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.24989999997316E-06 |
| Normal-vs-Age(61-80Yrs) |
9.34340382841015E-11 |
| Normal-vs-Age(81-100Yrs) |
1.2339999999611E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.045600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.297800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.469900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.311900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.63209998241365E-09 |
| Normal-VS-Type2 PRCC |
4.05690000482295E-08 |
| Normal-VS-KIRP CIMP |
4.264200E-01 |
| Normal-VS-Unclassified PRCC |
3.718700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.301600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.202100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.649820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.434200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.610200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.364400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.02400002208481E-10 |
| Normal-vs-N1 |
9.896300E-02 |
| Normal-vs-N2 |
3.710600E-01 |
| N0-vs-N1 |
2.993600E-02 |
| N0-vs-N2 |
3.004000E-01 |
| N1-vs-N2 |
7.714400E-01 |
|
|
